Profound Medical Corp
$ 6.62
3.12%
16 Apr - close price
- Market Cap 240,264,000 USD
- Current Price $ 6.62
- High / Low $ 6.68 / 6.26
- Stock P/E N/A
- Book Value 1.83
- EPS -1.41
- Next Earning Report 2026-05-14
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.35 %
- ROE -0.67 %
- 52 Week High 8.95
- 52 Week Low 3.76
About
Profound Medical Corp. The company is headquartered in Mississauga, Canada.
Analyst Target Price
$11.90
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-10 | 2025-11-13 | 2025-08-14 | 2025-05-07 | 2025-03-05 | 2024-11-07 | 2024-08-08 | 2024-05-09 | 2024-03-07 | 2023-11-02 | 2023-08-09 | 2023-05-10 |
| Reported EPS | -0.27 | 0.26 | -0.52 | -0.36 | -0.2 | -0.38 | -0.28 | -0.26 | -0.42 | -0.26 | -0.35 | -0.32 |
| Estimated EPS | -0.302 | -0.38 | -0.27 | -0.2825 | -0.3225 | -0.3 | -0.29 | -0.3 | -0.32 | -0.33 | -0.34 | -0.34 |
| Surprise | 0.032 | 0.64 | -0.25 | -0.0775 | 0.1225 | -0.08 | 0.01 | 0.04 | -0.1 | 0.07 | -0.01 | 0.02 |
| Surprise Percentage | 10.596% | 168.4211% | -92.5926% | -27.4336% | 37.9845% | -26.6667% | 3.4483% | 13.3333% | -31.25% | 21.2121% | -2.9412% | 5.8824% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-14 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -0.24 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: PROF
2026-04-16 20:09:08
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) will release its first quarter 2026 financial results after market close on Thursday, May 7, 2026. Management will host a conference call at 4:30 p.m. ET to discuss the results and business developments. Profound Medical is a commercial-stage medical device company focused on AI-powered, MRI-guided, incision-free therapies.
2026-04-16 13:39:46
Profound Medical, a commercial-stage medical device company specializing in AI-powered, MRI-guided incision-free therapies, has announced it will release its first-quarter 2026 financial results after market close on Thursday, May 7, 2026. This will be followed by a management-hosted conference call to discuss the results and business developments. The company's technologies, including TULSA-PRO and Sonalleve, are approved in major global markets.
2026-04-16 12:39:46
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) will release its first quarter 2026 financial results after market close on Thursday, May 7, 2026. The company, which specializes in AI-powered, MRI-guided incision-free therapies, will follow with a conference call at 4:30 p.m. ET to discuss the results and business developments. Profound Medical designs and markets technologies like TULSA-PRO® for prostate therapy and Sonalleve® for bone metastases and gynecologic conditions, all utilizing real-time MRI guidance.
2026-04-16 12:39:46
Profound Medical Corp. announced it will release its first-quarter 2026 financial results after market close on Thursday, May 7, 2026. The company will also host a conference call at 4:30 p.m. Eastern Time on the same day to discuss the results and business developments. Profound Medical specializes in AI-powered, MRI-guided, incision-free therapies, with flagship products like TULSA-PRO for prostate therapy and Sonalleve for various conditions including bone metastases and gynecologic treatments.
2026-04-15 16:11:48
This page provides a comprehensive resource for investors to access Profound Med Corp's SEC filings, including annual 10-K reports, quarterly 10-Q earnings, 8-K material events, and insider trading forms. Each filing is accompanied by AI-powered summaries to help users quickly grasp key information. Recent filings highlight operational milestones, financial results, distribution agreements, and equity financings, offering a detailed view of the company's regulatory and financial history.
2026-04-14 14:10:34
Profound Medical Corp. announced that its management will provide a business update at the 2026 Bloom Burton & Co. Healthcare Investor Conference. The presentation is scheduled for Wednesday, April 22, at 10:00 a.m. Eastern Time at the Metro Toronto Convention Centre. Following the announcement, shares of Profound Medical Corp. (T.PRN) were trading down $0.01 at $8.50.
